Feb 2, 2024, 12:20
Erman Akkus: Targeting p53 in cancer. Is it promising?
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X:
“Targeting p53 in cancer
Is it promising?
A very comprehensive review
- Mechanisms of drugs
- Ongoing clinical trials
- Protacs
- p53 and immune therapy
- p53 gene therapy
- The dependence of p53 in a specific cancer type?
- Need for biomarkers to select patients
- tissue specifity?
- Combination therapies?”
Read further.
Source: Erman Akkus/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14